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Abstract 
Objectives: this is a retrospective cross-sectional study designed to describe 
the pathological patterns of esophageal squamous cell carcinoma and to 
study the role of Human Papilloma Virus in its etiology in Sudan. 
Materials and Methods: The study included 107 paraffin embedded tissue 
blocks of endoscopic and total resection esophageal specimens diagnosed as 
esophageal squamous cell carcinoma at El Zahrawi Laboratory during the 
period from Jan 2000 to the middle of 2007. Data on patients’ 
demographics, location of the tumor, degree of differentiation, and lymph 
nodes status were obtained from the files of EL Zahrawi laboratory and were 
analyzed statistically using SPSS software. DNA was extracted from 35 
tumours and 11 adjacent normal mucosa. The material was subjected to PCR 
technique for detection of Human Papilloma Virus using type specific 
primers. 
Results: Carcinoma of the esophagus in this study occurred in two distinct 
age groups, below 40 years and 60-70 years. The majority of cases were 
females with a Male/Female ratio of 0.6/1. Where the data were available 
most of the tumors were located in the lower esophagus. Deep invasion with 
involvement of the esophageal muscle was the found in more than 50% of 
cases. More than ninety percent of lymph nodes accompanying total 
resection specimens showed deposition of carbon (anthracosis). Extracted 
DNA displayed high purity in the majority of cases. HPV type 16 was found 
in 8.5% of tumours and none of the adjacent normal mucosa (P< 0.001). 
HPV type 18 was found in 60% of the tumours and 70% of the normal 
mucosa (P> 0.05) respectively.  
viii 
 
Conclusions: Carcinoma of the esophagus in Sudan has two peaks of age 
distribution (<40 and 60-70 yrs). Females are more affected than males. 
Anthracosis in draining lymph nodes is almost a constant finding and needs 
more investigation. Human Papilloma Virus is a possible factor in the 
etiology of esophageal cancer in Sudan. This needs confirmation in a larger 
sample. 
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  ﻣﺴﺘﺨﻠﺺ
 ، و ﻟﺒﺤﺚ ئهﺬﻩ دراﺳﺔ ﻗﻬﻘﺮﻳﺔ ﻣﻘﻄﻌﻴﺔ ُﺻﻤﻤﺖ ﻟﻠﺘﻌﺮف ﻋﻠﻰ اﻟﺨﻮاص اﻟﻤﺮﺿﻴﺔ ﻟﺴﺮﻃﺎن اﻟﻤﺮ: اﻷهﺪاف
  .ﻓﻲ اﻟﺴﻮدان ئ آﻌﺎﻣﻞ ﻣﺴﺒﺐ ﻟﺴﺮﻃﺎن اﻟﻤﺮamollipaP namuHدور ﻓﻴﺮوس 
 ﻣﻦ ﻋﻴﻨﺎت اﻷﻧﺴﺠﺔ اﻟﻤﺜﺒﺘﺔ ﻓﻲ ﻗﻮاﻟﺐ اﻟﺒﺮاﻓﻴﻦ اﻟﻤﺄﺧﻮذة ﺑﺎﻟﻤﻨﻈﺎر و ﺑﺎﻷزاﻟﺔ 701 ﺷﻤﻠﺖ اﻟﺪراﺳﺔ :لﺌاﻟﻮﺳﺎ
ﺠﺮاﺣﻴﺔ اﻟﻜﺎﻣﻠﺔ ﻟﺴﺮﻃﺎن اﻟﻤﺮئ، واﻟﺘﻲ أﺛﺒﺖ ﻓﻴﻬﺎ ﺗﺸﺨﻴﺺ ﺳﺮﻃﺎن اﻟﺨﻠﻴﺔ اﻟﻈﻬﺎرﻳﺔ ﺑﻤﻌﻤﻞ اﻟﺰهﺮاوي اﻟ
آﻞ اﻟﻤﻌﻠﻮﻣﺎت ﻓﻴﻤﺎ ﻳﺨﺘﺺ . 7002 و ﺣﺘﻰ ﻣﻨﺘﺼﻒ اﻟﻌﺎم 0002ﻟﻸﻧﺴﺠﺔ اﻟﻤﺮﻳﻀﺔ ﻓﻲ اﻟﻔﺘﺮة ﻣﺎ ﺑﻴﻦ ﻳﻨﺎﻳﺮ 
ﺪد اﻟﻠﻴﻤﻔﺎوﻳﺔ ، درﺟﺔ ﺗﺨﻠﻖ اﻟﺨﻼﻳﺎ اﻟﻈﻬﺎرﻳﺔ، وﺣﺎﻟﺔ اﻟﻐئﺑﻌﻤﺮ و ﺟﻨﺲ اﻟﻤﺮﺿﻰ، ﻣﻮﻗﻊ اﻟﻮرم ﻓﻲ اﻟﻤﺮ
اﻟﻤﺼﺎﺣﺒﺔ؛ ﺗﻢ اﻟﺘﺤﺼﻞ ﻋﻠﻴﻬﺎ ﻣﻦ ﻣﻠﻔﺎت اﻟﻤﺮﺿﻰ ﺑﻤﻌﻤﻞ اﻟﺰهﺮاوي ﺛﻢ ﺣﻠﻠﺖ إﺣﺼﺎﺋﻴﺎ ﺑﺈﺳﺘﺨﺪام ﺑﺮﻧﺎﻣﺞ 
 ﻋﻴﻨﺔ ﻣﻦ أﻧﺴﺠﺔ ﺳﻠﻴﻤﺔ 11 ﻋﻴﻨﺔ ﺳﺮﻃﺎﻧﻴﺔ و53 ﻣﻦ ANDﺗﻢ إﺳﺘﺨﺮاج اﻟﺤﻤﺾ اﻟﻨﻮوي . SSPSاﻟﺤﺎﺳﻮب 
 اﻟﻤﺴﺘﺨﺮﺟﺔ ﻓﻲ ﺗﻔﺎﻋﻞ اﻟﺴﻠﺴﻠﺔ إﺳﺘﺨﺪﻣﺖ اﻟﻤﺎدة. ﻣﻦ ﺑﻄﺎﻧﺔ اﻟﻤﺮئ ﻓﻲ ﺣﻮاف ﻋﻴﻨﺎت اﻹزاﻟﺔ اﻟﻜﺎﻣﻠﺔ ﻟﻠﺴﺮﻃﺎن
  .  ﺑﻮاﺳﻄﺔ ﻣﺒﺘﺪﺋﺎت ﻣﺤﺪدة ﻟﻠﻨﻮع amollipaP namuH ﻟﻠﻜﺸﻒ ﻋﻦ وﺟﻮد اﻟﻔﻴﺮوسRCPاﻟﺒﻠﻤﺮي 
 07 -06 ﺳﻨﺔ و ﻣﻦ 04ﺳﺮﻃﺎن اﻟﻤﺮئ ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ وﺟﺪ ﻓﻲ ﻓﺌﺘﻴﻦ ﻣﺨﺘﻠﻔﺘﻴﻦ ﻣﻦ اﻟﻌﻤﺮ؛ أﻗﻞ ﻣﻦ  :جﺌاﻟﻨﺘﺎ
ﻋﻨﺪ ﺗﻮﻓﺮ هﺬﻩ اﻟﻤﻌﻠﻮﻣﺔ ﻓﺈن ﻣﻌﻈﻢ . 6.0/1ي ﻧﺴﺎء ﺗﺴﺎو/ﻏﺎﻟﺒﻴﺔ اﻟﻤﺼﺎﺑﻴﻦ هﻢ ﻣﻦ اﻟﻨﺴﺎء، ﺑﻨﺴﺒﺔ رﺟﺎل. ﺳﻨﺔ
وﺟﺪ اﻟﻐﺰو اﻟﻌﻤﻴﻖ ﺣﺘﻰ ﻋﻀﻼت اﻟﻤﺮئ ﻓﻲ أآﺜﺮ ﻣﻦ ﺧﻤﺴﻴﻦ . ئاﻷورام وﺟﺪت ﻓﻲ اﻟﺜﻠﺚ اﻷﺳﻔﻞ ﻣﻦ اﻟﻤﺮ
اآﺜﺮ ﻣﻦ ﺗﺴﻌﻴﻦ ﺑﺎﻟﻤﺌﺔ ﻣﻦ اﻟﻐﺪد اﻟﻠﻴﻤﻔﺎوﻳﺔ اﻟﻤﺼﺎﺣﺒﺔ ﻟﻌﻴﻨﺎت اﻷزاﻟﺔ اﻟﻜﺎﻣﻠﺔ . ﺑﺎﻟﻤﺌﺔ ﻣﻦ ﻣﺠﻤﻮﻋﺔ اﻟﺪراﺳﺔ
اﻟﺤﻤﺾ اﻟﻨﻮوي اﻟﻤﺘﺤﺼﻞ أﻇﻬﺮ درﺟﺎت ﻋﺎﻟﻴﺔ ﻣﻦ اﻟﻨﻘﺎء ﻓﻲ ﻣﻌﻈﻢ . ﺒﺔ ﺑﻬﺎأﻇﻬﺮت وﺟﻮد ﻣﻮاد آﺮﺑﻮﻧﻴﺔ ﻣﺘﺮﺳ
ﻣﻦ اﻟﻌﻴﻨﺎت اﻟﺴﺮﻃﺎﻧﻴﺔ و ﻟﻢ ﻳﻮﺟﺪ ﻓﻲ أي ﻣﻦ % 8  5. ﻓﻲ61 اﻟﻨﻮع VPHإﺗﻀﺢ وﺟﻮد اﻟﻔﻴﺮوس . اﻟﺤﺎﻻت
% 07اﻟﻌﻴﻨﺎت اﻟﺴﺮﻃﺎﻧﻴﺔ و ﻓﻲ  ﻣﻦ% 06 ُوﺟﺪ ﻓﻲ 81 اﻟﻨﻮع VPH. 00.0 <P(1)اﻟﺨﻼﻳﺎ اﻟﺴﻠﻴﻤﺔ اﻟﻤﺠﺎورة 
  . ﻋﻠﻰ اﻟﺘﻮاﻟﻲP(  )50.0>اﻟﺴﻠﻴﻤﺔ اﻟﻤﺠﺎورةﻣﻦ اﻟﺨﻼﻳﺎ 
اﻟﻨﺴﺎء (.  ﺳﻨﺔ07-06 و ﻣﻦ 04أﻗﻞ ﻣﻦ )  ﻓﻲ اﻟﺴﻮدان ﻳﺘﻮاﺟﺪ ﻓﻲ ﻓﺌﺘﻴﻦ ﻣﻦ اﻟﻌﻤﺮ ئﺳﺮﻃﺎن اﻟﻤﺮ: اﻟﺨﻼﺻﺔ
 ﻓﻲ آﻞ ئوﺟﻮد ﺗﺮﺳﺒﺎت آﺮﺑﻮﻧﻴﺔ ﻓﻲ اﻟﻐﺪد اﻟﻠﻴﻤﻔﺎوﻳﺔ اﻟﻤﺠﺎورة ﻟﻠﻤﺮ. أآﺜﺮ إﺻﺎﺑﺔ ﺑﺎﻟﻤﺮض ﻣﻦ اﻟﺮﺟﺎل
 هﻮ ﻋﺎﻣﻞ ﻣﺴِﺒﺐ ﻣﺤﺘﻤﻞ ﺑﺎﻟﻨﺴﺒﺔ VPHﻓﻴﺮوس . ﺤﻖ ﻣﺰﻳﺪا ﻣﻦ اﻟﺒﺤﺚاﻟﻌﻴﻨﺎت ﺗﻘﺮﻳﺒﺎ هﻮ ﻇﺎهﺮة واﺿﺤﺔ ﺗﺴﺘ
 .ﻳﺠﺐ دراﺳﺔ ﻣﺠﻤﻮﻋﺎت أآﺒﺮ ﻟﻠﺘﺄآﺪ ﻣﻦ ﻃﺒﻴﻌﺔ اﻟﺪور اﻟﺬي ﻳﻠﻌﺒﻪ ﻓﻲ هﺬا اﻟﻤﺠﺎل. ئﻟﺴﺮﻃﺎن اﻟﻤﺮ
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Chapter one
 2
Introduction &Literature Review 
 
 
Normal anatomy and histology: 
The normal esophagus is a hollow highly distensible muscular tube that 
extends from the epiglottis in the pharynx (at the level of C6 vertebra) to the gastro-
esophageal junction (at the level of T11 or T12 vertebra) 1. Measuring about 25 cm in 
the adult, the esophagus is arbitrarily divided into three parts: the cervical part, the 
thoracic esophagus, and the abdominal esophagus. Clinically, the thoracic esophagus 
is divided into three parts. The upper thoracic esophagus extends from the 
cricopharyngeus to the level of the carina. The middle thoracic esophagus extends 
from the level of the carina to halfway between the carina and the esophago-gastric 
junction and the lower thoracic esophagus from halfway between the carina and the 
esophago-gastric junction to include the lower third of the esophagus. Oncologically, 
the thoracic esophagus is divided into the supra-carinal esophagus (upper esophagus) 
and the infra-carinal esophagus (middle and lower esophagus) 2. The wall of the 
esophagus consists of a mucosa, submucosa, muscularis propria, and adventitia. The 
lining epithelium is of a non-keratinized stratified squamous type.1     
Blood supply and lymphatic drainage: 
The esophagus receives a segmental arterial supply from several small 
arterioles throughout its course. The arterioles terminate in a fine capillary network 
before they penetrate the muscular wall, after which they join to form another 
submucosal capillary plexus. 
The venous drainage is to the inferior thyroid and hypopharyngeal veins in the 
neck, the azygus, hemiazygus and intercostals veins in the chest, except at the lower 
end which drains into the left gastric vein. 
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The lymphatics form extensive mucosal ( lamina propria), submucosal, 
muscularis and adventitial plexuses which communicate freely, and lymph flows long 
distances in the large submucosal plexus before passing through the muscular coat to 
reach the adventitial plexus and draining lymph nodes. These are grouped into three: 
the first are the para-esophageal, the second are the mediastinal group, and third level 
nodes; deep cervical, supraclavicular, trachea-bronchial, and coeliac nodes. In general 
the upper two thirds of the esophagus drain in a proximal direction towards the 
cervical region whereas the lower third drains distally to sub-diaphragmatic region 
and celiac lymph nodes 2.   
Epidemiology, morbidity, and mortality:   
Esophageal cancer is one of the most serious malignant diseases, owing to its 
rapid development and fatal outcome in most cases 3. It is the sixth most frequent 
tumor disease worldwide with an incidence rate of 11.5/100 000 3, 4. The incidence of 
the tumor increases with age with the highest incidence in the age group 50–70 years. 
The disease is diagnosed more frequently in males than in females with an 
approximate ratio of 3–5:1. The most frequent histological type is squamous cell 
carcinoma. The proportion of adenocarcinomas has increased from 3.5 % in 1985 to 
17.0 % by the year 2000 according to reviewed data from several countries 3. 
However, In Western Europe and the U.S.A., the proportion of adenocarcinomas is 
almost 50 %.. Cummings LC, conducted a study in USA (2008-04-29) aimed to 
compare incidence rates of esophageal adenocarcinoma (EAC) and squamous cell 
carcinoma (ESCC) by race. The study concluded that African-Americans had higher 
ESCC incidence than whites (5.0 versus1.3 cases/100,000/year). However, whites had 
higher EAC incidence (3.3 versus 0.8 cases/100,000/year) 5. 
Esophageal Squamous Cell Carcinoma (ESCC): 
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One of the features of squamous cell carcinoma of the oesophagus is the 
fragmentation of its incidence into low risk and high risk areas, based on geographical 
location. Some of the low risk areas include North America, countries in Western 
Asia, and Northern and Southern Europe, where the incidence rates range from 1.5 to 
6.0/100,000. And well defined high risk areas include South Africa, China, Iran and 
countries in Eastern Africa, where the incidence rates range from 10 to 25/100,000 5 . 
Furthermore, within these high risk areas, there are regions, such as the Transkei 
region in South Africa, and northern parts of China, where the incidence rates are 
substantially higher 6. 
Esophageal cancer in Sudan 
In Sudan, the magnitude of cancer esophagus was recognized since the mid 
70s when 106 cases were reported together with other alimentary tract malignancies 7. 
Esophageal cancer was found to be the commonest GI malignant tumor making about 
19.4%, and 1.3% of all malignancies registered at that time. Fifty one were males and 
55 were females, giving an M: F ratio of 0.9: 1. The maximum incidence reported was 
in the 6th and 7th decades: however, of the cases where the age was known, more 
than half occurred before 60. Regarding the site of tumor, it was noted that in women 
30% of the lesions occurred in the upper third, 63% in the middle third, and 7% in the 
lower third. The corresponding percentages for men were 4, 20, and 76%, 
respectively. Grossly, the tumors were usually of ulcerative type with a varying 
degree of infiltration in both longitudinal and transverse directions. Histologically, 
there were 98 squamous cell carcinomas (92.5%), five adenocarcinomas (4.7%), and 
three anaplastic carcinomas (2.8%). All the five adenocarcinomas were in the lower 
third and, interestingly, all of them were in males 7, 8. In 1993, Ahmed had reported an 
increase in the relative incidence of cancer esophagus of 4.6%, in Sudan compared to 
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studies done in the 70s 9. During the same period, Hamo I.M. had found that cancer 
esophagus was diagnosed in 2.1% of 5086 patients who underwent upper GI 
endoscopy for different reasons.10 
Etiology and pathogenesis: 
The risk factors involved in the etiology of the disease and the reasons for the 
geographical variation are poorly understood, but it is known that factors that cause 
inflammation and chronic irritation to the esophagus increase the risk of squamous 
cell carcinoma. Multiple factors such as alcohol and tobacco consumption, nutritional 
deficiencies, socioeconomic status and chemicals such as nitrosamines have been 
implicated1, 11. The genetic disorder, tylosis A,  characterized by an abnormality at 
chromosome 17q25 also confers increased risk to ESCC; however, it is rare.11-15 
Nitrosamines are well recognized carcinogens and are found in high concentrations in 
foods of areas endemic for cancer esophagus. Many of these compounds are readily 
formed from common precursors in the environment (e.g. in food during its storage or 
preparation) and also in vivo in the human stomach.16  Mechanical factors which have 
been cited include drinking extremely hot beverages and consumption of foods 
containing silica or other substances, such as crushed seeds, that directly irritate the 
esophagus16, 17. Deficiencies of folic acid, vitamins A, C, and riboflavin, 
molybdenum, and selenium also have been implicated in the development of 
esophageal neoplasms 18-20 
In the western hemisphere, social factors figure more prominently in the 
development of esophageal cancer. Heavy alcohol consumption increases the risk of 
cancer 10 to 25 times, depending on the concentration of alcohol in the beverage. 21 
Cigarette smoking has been linked to the development of both squamous cell cancers 
and adenocarcinomas. 22 The combined exposure to low levels of tobacco and alcohol 
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increases the risk of esophageal cancer by a factor of 10 to 20, whereas the synergistic 
effect of exposure to high levels of both alcohol and tobacco increases the risk by a 
factor of over 100 23. 
 Chronic gastro-esophageal reflux is believed to be etiologically related to the 
development of Barrett esophagus which occurs primarily in white males and is 
associated with a 40-fold increase in the risk of adenocarcinoma of the esophagus. 24 
A relationship between reflux and the development of squamous cell cancers has also 
been suggested in patients who consume a diet high in linoleic acid.25   The lifetime 
risk of squamous cell cancer of the esophagus is 5% to 10% in patients with 
esophageal achalasia, a 15-fold increase in incidence that is likely due to chronic 
irritation from retained food26- 28. Corrosive strictures are also regarded as a 
predisposing to ESCC49.  
Race and gender are associated with varying incidences of cancer of the 
esophagus in the western hemisphere. Men are more commonly affected than are 
women, blacks develop squamous cell cancers more often than do whites, and white 
males develop adenocarcinomas more often than do females or individuals of other 
race groups.29  However, none of these increased frequencies has yet been linked to 
genetic factors, and most have been explained by variations in socioeconomic status 
and the attendant social habits described earlier. The single proven genetic 
abnormality that is associated with a 25% lifetime incidence of squamous cell cancer 
of the esophagus is tylosis A, the late-onset, familial form of palmer and plantar 
hyperkeratosis. 30  
 A number of genetic alterations are associated with neoplasms of the 
esophagus, including allelic losses at chromosomes 3p, 5q, 9p, 9q, 13q, 17p, 17q, and 
18q. Mutations of p53 (mostly missense), Rb (deletions), cyclin D1 (amplifications) 
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and c-myc (amplifications), are also associated with esophageal cancer 
development31. Other molecular markers of ESCC are DNA aneuploidy, and a high 
proliferative index; their presence also indicates aggressive behavior .49    
 
Pathology and Classification 
      The main histological subtypes of carcinoma of the esophagus according to the 
WHO criteria of classification, 32 are: 
1. Squamous cell carcinoma. 
2. Adenocarcinoma arising in Barrett’s. 
3. Adenoid cystic carcinoma. 
4. Mucoepidermoid carcinoma. 
5. Adenosquamous carcinoma. 
6. Undifferentiated carcinoma.  
Variants of ESCC include 32: Spindle cell SCC, Verrucous SCC, Basaloid SCC, and 
 EBV-associated, lymphoepithelioma like SCC. 
Pathological patterns of ESCC: 
Squamous cell carcinoma is the most common type and accounts for >90% of 
all esophageal malignancies. Like other squamous epithelial malignancies, ESCC may 
commence as in-situ lesions1.  
Location: 
Twenty percent of tumors occur in the upper third, 50% in the middle third, 
and 30% in the lower third1. 
Configuration:  
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Like other GI malignancies, ESCC grow in three patterns:  deep irregular ulcer 
(25%), fungating exophytic growth (60%) , and plaque like stenosing mural 
thickenings (15%)1,2 .  
Clinical picture:  
Asymptomatic course and Late presentation of most esophageal malignancies; 
are the major causes of the deadly outcome in most cases1, 2. 
Progressive dysphagia may not be obvious until two thirds of the lumen is obliterated 
by the tumor2. Oesophageal obstruction will result in malnutrition, weight loss, 
regurgitation, and occasionally aspiration2.  
Growth of esophageal cancer (ESCC or EAC) occurs by intra-esophageal 
spread, direct extension, and lymphatic or hematogenous spread. ESCC more 
typically invades adjacent structures than EAC. Distant metastasis may be present in 
25- 30% of ESCC patients at the time of diagnosis and in up to 50% of patients at 
autopsy. The liver (32%), lungs (21%), and bones are the most frequent sites2. 
Histogenesis: 
  Squamous cell carcinoma (SCC) is defined as an epithelial malignancy with 
morphologic features of squamous cell differentiation without additional features 
suggestive of other differentiated tissues. The features of squamous differentiation, 
observable on routine stained tissues under light microscopy, include one or more of 
the following: (1) flattened polyhedral, round, or ovoid epithelial cells; (2) 
intracellular or extracellular keratinization; and (3) intercellular bridges.33  
Regarding the degree of differentiation (grade), moderate to well differentiate 
comprise the majority of ESCC and the rest are poorly differentiated1. 
Pathological staging: 
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The AJCC revised the TNM system of staging to become more valuable from 
a prognostic point of view, in the following way: 34 
Definition of TNM  
Primary tumor (T)  
TX Primary tumor cannot be assessed  
T0 No evidence of primary tumor  
Tis Carcinoma in situ  
T1 Tumor invades lamina propria or submucosa  
T2 Tumor invades muscularis propria  
T3 Tumor invades adventitia  
T4 Tumor invades nearby structures  
Regional lymph nodes (N)  
NX Regional lymph nodes cannot be assessed  
N0 No regional lymph node metastasis  
N1 Regional lymph node metastasis  
Distant metastasis (M)  
MX Distant metastasis cannot be assessed  
M0 No distant metastasis  
M1 Distant metastasis  
Tumors of the lower thoracic esophagus:  
M1a Metastasis in celiac lymph nodes  
M1b Other distant metastasis  
Tumors of the midthoracic esophagus:  
M1a Not applicable  
M1b Nonregional lymph nodes and/or other distant metastasis  
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Tumors of the upper thoracic esophagus:  
M1a Metastasis in cervical nodes  
M1b Other distant metastasis  
 
Stage grouping 
Stage 0 Tis N0 M0 
Stage I T1 N0 M0 
Stage IIA T2 N0 M0 
 T3 N0 M0 
Stage IIB T1 N1 M0 
 T2 N1 M0 
Stage III T3 N1 M0 
 T4 Any N M0 
Stage IV Any T Any N M1 
Stage IVA Any T Any N M1a 
Stage IVB Any T Any N M1b 
 
 
Prognosis: 
The prognosis of esophageal cancer is generally unfavorable, even when the 
tumor is surgically removed at its early and operable stage. The most reliable 
prognostic indicators are the degree of penetration of the wall, and the involvement of 
lymph nodes. The overall five-year survival rate is less than 5 % 1,3,4 . 
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The role of viruses  
Many viruses have been shown to have oncogenic potential, such as hepatitis 
B virus linked to cancer of the liver, Epstein-Barr virus to nasopharyngeal carcinoma, 
and human papilloma virus (HPV) to carcinoma of the cervix 35. Recently, an 
association between viral infection and the development of esophageal carcinoma has 
been reported, particularly the human papilloma virus (HPV) and Esptein-Bar virus 
(EBV) 35. 
          The evidence of HPV infection in esophageal SCC is mixed and shows 
geographical variations among high prevalence areas 36. Studies from some high 
prevalence regions report integrated HPV- DNA in up to 71% of Esophageal SCC, 
but most studies from North America and northern Europe show little or no HPV- 
DNA in esophageal squamous cell malignancies 36. 
 
The Human Papilloma Virus (HPV):  
Human papillomaviruses (HPVs) are a large group of small, non-enveloped, 
double-stranded DNA viruses. Infection with HPV typically leads to benign epithelial 
proliferations; however, a growing number of viral subsets have been associated with 
epithelial cancers. Malignant transformation, if it occurs, tends to occur after a long 
latency period, reflecting that infection with HPV is necessary but not sufficient for 
the development of HPV-associated cancers.37 
The frequency of detection of HPV DNA in ESCC is highly variable, ranging 
from 0 to 70% 38 in different geographic areas 39- 42. The great variation in the 
association between HPV and ESCC worldwide may be due to environmental and 
geographic factors, genetic susceptibility to esophageal HPV infections, or to 
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variations in the sensitivity of techniques used in the detection of the virus and in the 
methodology for processing the tumor tissues 6, 38. Studies from China identified 
detection rates of HPV DNA in esophageal cancer, ranging from 40 to 60% 43.44. 
Other high-incidence areas , including the Far East and South Africa 45, 46, also 
implicated HPV infection as a risk factor in the development of ESCC 47- 49 .  
Molecular pathogenesis: 
Transforming proteins E6 and E7 from the high risk sub-types 16 and 18, 
interact with p53 protein and Rb protein respectively, leading to loss of function of 
these tumor suppressor gene products. These interactions further lead to inactivation 
of the growth suppressive effects of the p53 and Rb proteins, resulting in abnormal 
proliferative states. p53 protein expression has been found in both HPV-positive and -
negative tumors, indicating that HPV and p53 protein expression are not mutually 
exclusive and can occur together in the same tumor. It has been observed that HPV 
plays a more significant role in esophageal carcinogenesis in geographic areas with a 
high prevalence of the disease. Esophageal carcinogenesis is a complex multistep 
process with a multifactorial etiology. Infection with oncogenic HPV types may be an 
integral part in a multistep process that leads to ESCC 6.  
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Objectives 
 
1. General Objectives: 
1.1 To describe the pathological patterns of ESCC in Sudan. 
1.2 To study the role of viruses in the pathogenesis of ESCC in Sudan. 
 
2. Specific Objectives: 
2.1 To study the site, degree of differentiation, depth, and Lymph node status 
in ESCC in Sudanese patients. 
2.2 To identify the role of HPV 16 and 18 as possible causative pathogens for         
ESCC in Sudanese patients. 
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Patients and Methods 
 
Study design: 
This is a retrospective (cross-sectional), descriptive and analytical study. 
 
Study population and study area:  
The study included 107 tissue specimens obtained from 79 patients diagnosed 
at Elzahrawi laboratory as esophageal squamous cell carcinoma. Thirty five paraffin 
embedded tissue blocks (PET) from 20 ESCC patients were selected according to the 
criteria below and subjected to molecular analysis together with 11 PET from non-
malignant surrounding esophageal mucosa of 9 patients, as internal controls.  
 
Specimen collection and identification: 
All issued reports from Elzahrawi laboratory during the period 2001- 2007 
were revised to obtain the lab numbers of all cases diagnosed as ESCC. Tissue blocks 
and slides were collected accordingly. Slides were revised for selection of blocks 
containing tumour and controls i.e. tissue blocks containing normal mucosa. 
All samples were treated anonymously, using untraceable bench numbers. 
 
Inclusion criteria: 
1. Sudanese nationality.  
2. Histopathological diagnosis of esophageal squamous cell carcinoma.  
Exclusion criteria: 
1. Failure to find paraffin blocks and/or slides. 
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2. Tissue blocks with surface area less than 0.3 cm2 were excluded from 
molecular analysis. 
 
 Materials and methods: 
Preparation of paraffin blocks: 
 The procedure started inside the endoscopy unit or operating room, when the 
surgeon takes a biopsy or whole esophageal resection specimen and places it in 
formalin for fixation. The purpose of fixation is to preserve tissues permanently in the 
best possible life-like state. Formalin is an aldehyde and very popular fixative; it has 
been used for hundreds of years. It works by causing cross-linking of biomolecules, 
that’s why special treatment with ethanol during extraction is needed to remove the 
negative effects of formalin on DNA. Surgical pathologists then examined the 
specimen grossly to select and cut representative tissue sections to be subjected to 
variable stages in tissue processing. Tissue processing is meant to make it possible to 
obtain thin sections (3-10 microns) out of tissues Processing involves the following 
steps: dehydration in graded alcohol, clearing in xylene, and impregnation in paraffin. 
Processed tissues were then embedded in paraffin to become paraffin embedded tissue 
blocks (PET), which could be sliced by the microtome. 
Staining with Haematoxilin and Eosin (H&E):  
 Thin tissue sections on glass slides were dewaxed, cleared by xylene, and 
brought to water.  Staining by water soluble conventional H&E stain was performed 
on all specimens. Haematoxilin is a basic blue dye that stains nuclei, and eosin is an 
acidic red dye used as a counter stain for haematoxilin. H&E staining is regarded by 
many as the most useful test in the histopathology laboratory. 
Histopathology data collection: 
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H&E stained slides were re-examined under the light microscope, and data on 
certain variables recorded. These include; revision of the diagnosis when necessary, 
recording the degree of differentiation (grade), the depth of invasion, and the status of 
lymph nodes accompanying resection specimens.  
The tissue surface area in paraffin blocks was crudely measured, calculated, 
and recorded in square centimeters. Serial, 10µm thick sections were obtained with a 
standard microtome and disposable blades. A different number of sliced paraffin 
embedded tissue (PET) sections were then placed in individual, sterile 1.5-mL 
ependorf tube according to the section surface area: 7 or 4 sections when, < 1cm2, or 
>1 cm2, respectively. Measures to avoid cross contamination during sectioning were 
strictly followed. These include decontamination of bench areas and the forceps used 
to pick the section, the use of disposable blades, and wearing lab coats and gloves. 
The cases and control tubes were properly labeled. 
Molecular techniques: 
1. DNA Extraction: 
 
Deparaffination of PET sections (dewaxing): 
The following steps were done according to manufacturer (GenoMed- 
JETQUICK tissue DNA spin kit, Lőhne- Germany) recommendations: 1ml xyline+ 
200µl absolute ethanol was added to tissue sections in each ependorf tube, vortexed 
for 20 seconds, incubated at room temp (RT) for 5 min, then spinned down for 10min 
at maximum speed. This step was repeated. Then pellets were re-suspended in 1ml 
absolute ethanol (100%) for 5 min and spinned down as previously mentioned. This 
step was also repeated. Then pellets were allowed to dry at room temperature, for 15 
min.  
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Extraction of PET-DNA: 
DNA was extracted using a commercial kit (GenoMed- JETQUICK tissue 
DNA spin kit; Lőhne- Germany); the protocol in this kit is a modification of the 
method published by Bowtell (1987). Extraction procedure was performed as 
described by the manufacturer’s manual with minor modifications. The kit expects an 
average length of extracted DNA less than 650 bp due to high sheer forces in the 
micro spin system. DNA was eluted with only 50 µl (not 100) of elution buffer to  
ensure higher concentration of eluate.   
 
Quantitative and qualitative estimation of DNA yields: 
 DNA was assessed spectrophotometrically using a Nano-drop instrument and 
its quantity recorded as ng/µl concentration. The purity of DNA was valuated by the 
A260/A280 ratio, with the range 1.7- 1.9 taken as acceptable according to the 
manufacturer's recommendations. DNA was stored at – 20°C until used. 
 
2. Amplification by conventional PCR: 
 Polymerase chain reaction is an amplification technique that employs a 
thermal cycler machine to create cycles of changing temperature. It is based on three 
simple steps required for any DNA synthesis reactions:  
1. Denaturation: heating to ~95°C to break hydrogen bonds in template DNA. 
2. Annealing: cooling to allow oligonucleotide primers to hybridize to target 
regions in template DNA; any primer has its own annealing temp. 
3. Elongation: heating to 72°C, the optimum temp of Taq (Thermus. aquaticus) 
polymerase enzyme. 
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Detection of HPV: 
Two sets of type specific HPV primers were used. See below 
Primer Sequence Size of PCR product 
HPV16 F5':TTTTGGGTTACACATTTACAAG 
R: TGTCTGCTTTTATACTAACCG 
119 
HPV18 F: GACACCTTAATGAAAAACGACGA 
R: CGTCGTTGGAGTCGTTCCTG 
112 
 
Preparation of master mix: 
 The reaction conditions that worked for both type-specific HPV primers, were 
as follows: in total volumes of 25µl, the master mix consisted of, 2.5 µl of 10x PCR 
buffer (10 m MTris-HCl (PH 8.3), 50 mM KCl), 2 µl of 10 mM dNTPs mix (2.5mM 
dATP, 2.5 mM dGTP, 2.5 mM dCTP, and 2.5 mM dTTP), 3.0 µl of 50 mM MgCl2, 
1Uof Taq polymerase (5U/µl), 1µl from each forward and reverse primers, 5µl from 
template DNA, and the volume is completed to 25µl by double distilled water.  
Quality control: 
A negative control (all reagents except DNA), and a positive control (known positive 
DNA template from cervical SCC) was used with each batch  
 
Thermal cycler program: 
 The program used was a classical one with the following steps: lead heat at 
110°C, 1st step 94°C for 5 min then 35 cycles of 94°C for 1 minute, annealing at 
55°C for1 min, and extension of primers at 72°C for1 minute, then final extension at 
72°C for 10 min, and cooling to 22°C and storage at 8°C. 
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3. Detection of PCR product:  
 Agrose gel electrophoresis was the method used for detection of the product. 
Ten µl of the product was mixed with 5 µl of the loading dye (6x bromophenol blue) 
in a Para film, then loaded in a settled 2% agrose gel wells, placed in electrophoresis 
plate containing 1:20 TBE buffer, and connected to electrical power supply. The 
power supply used was fixed at 50mV to run a current around 0.4 amperes for 30 min. 
These settings allowed migration of the product; half to two thirds of the gel field. A 
100bp DNA marker was used to identify the size of the product band. 
Visualization system: 
    Ethidium bromide staining of gels was carried out to be viewed under UV 
light and photographs taken in a computerized gel documentation system. The size of 
bands was identified by comparison with the marker DNA. 
 
Data analysis 
All the data was recorded in an SPSS software (version 10) data sheet and  analyzed 
using descriptive statistic technique. Numerical data like age, was analyzed using the 
mean as an indicator of location and the standard deviation (SD) for measuring 
dispersion. For nominal data (as is the case in the rest of the variables) description of 
frequencies in the form of percentage was the analytical method used.  Results of data 
analysis were presented in the form of tables, figures and chart with the aid of the 
Microsoft office Excel 2003 and Statistical Package for Social Sciences (SPSS) 
software. Correlate analysis was performed as necessary using the Pearson correlate-
chi square test and the P value extracted as an indicator of significance. 
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Results 
 
The mean age of the study group was 54.74±13.88 years. The minimum age 
was 22 years and the maximum one was 91 years (refer to table 1). Age distribution 
showed two peaks, one around 35 and the other around 60 years of age as shown in 
Figure 1. 
Sixty two percent (n= 66/107) of the study group were found to be females 
compared to only 38% (n= 41/107) who were males with a male/female ratio of 0.6/1. 
(See Figure 2) 
Regarding the site of the tumor on endoscope as described by clinicians, only 
52.3% (n= 56) had the site documented in the request form whereas it was missing in 
47.7% (n= 51) of the study group. Of those reported 62.5 % (n=35 of 56) were in the 
lower third of the esophagus, 33.9% (n=19) in the middle third, and only 3.6% (n= 2) 
were in the upper third. (Table 2) 
Referring to tumor grade, 38 (35.5%) patients had poorly differentiated SCC, 
68 (63.5%) had well to moderately differentiated SCC, and sarcomatoid SCC was 
reported in only one patient. (Figure 3)  
Depth of tumor invasion was difficult to evaluate in the great majority of 
cases, comprising 56.1% (n= 60). In the rest, Deep invasion down to the muscles was 
the case in 41.1% (n= 44), submucosal invasion in 0.9% (n= 1), and mucosal in 1.9% 
(n=2). (Table 3) 
Lymph node biopsy accompanied only 23.4% (n=25 out of 107) of tissue 
specimens, of those 96% (n=24 out of 25) showed anthracosis (Table 4 and Figure 4). 
This rather new finding was statistically analyzed using Pearson correlation test but; 
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neither of the variables was significantly related to anthracosis (age, gender, the tumor 
grade, and the presence of the HPV).  
The decision on whether or not to extract DNA from paraffin blocks was taken 
in accordance to the surface area of the tissue embedded in paraffin so as to assure 
extraction of good quantity of DNA without overwhelming the micro spin column 
silica filters with big weights. 51   
The total number of cases included in molecular analysis was 35/107 from the 
study group and 11/11 of the control group. The rest of the study group (67.3%, n=72) 
were excluded. 
The extracted DNA form the study group ranged from as low as 6.9 to as high 
as 521.0 ng/µl with a mean concentration of 142.9+/-112.4. Regarding DNA extracted 
from apparently normal tissue i.e. the control group, concentrations ranged from 25.7 
to 180.5 with mean concentration of 85.8+/- 58.5 ng/µl. (Table 5)  
These wide ranges of different concentrations may be attributed to variability 
in the following: the DNA content in malignant tissue, the presence and proportion of 
necrosis, the type and duration of fixation, and the age and storage conditions of PET 
51. DNA content may vary according to the type, aggression and the proliferative state 
of an individual tumor. Fixation by formalin as is the case in our study may negatively 
affect DNA yields especially when un-buffered, as well as very long duration of 
fixation.  
The purity of extracted DNA was generally acceptable in both the study and 
the control groups, mainly attributable to the standardized kit’s reagents. Expressed as 
the ratio A (absorbance) 260/A280, results of DNA purity showed 88.5% (n= 31) 
falling in the acceptable to high purity zone, and only 11.4% (n=4) had reported 
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purity of <1.7. In controls 90.9% gave reading between <1.7- >1.9 (n= 10/11) the rest 
report <1.7 (9%, n=1). (Table 6) 
Concerning results of PCR amplification of viral genes in extracted DNA, 
HPV type 16 genes were positive in 3 of the study group (8.5%), and none of the 
controls (0%) the difference was statistically significant using chi square test 
(P=0.000). HPV type 18 gave positive results in 21 of the study group (60%), and 7 of 
the controls (63.6%), the difference was statistically insignificant also using chi 
square test, (P = 0.237). (Tables 7 and 8) 
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Tables and graphs 
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Table (1): Age distribution among the study group. 
 
 Number Minimum Maximum Mean Std. 
deviation 
Age (study 
group) 
107 22 91 54.83 13.88 
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Figure (1): Age distribution among the study group 
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Figure 2: Gender Distribution among study 
group
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Figure (2): Sex distribution among the study group. 
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Table (2): Site of the tumor on endoscopy 
 
 Number  Percent Valid percent 
Upper third 2 1.9 3.6 
Middle third 19 17.8 33.9 
Lower third 35 32.7 62.5 
Total 56  52.3 100.0 
Missing  51 47.7  
Total  107 100.0  
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Figure (3): The grade of ESCC among the study group, in numbers. 
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Table (3): Depth of invasion by the tumor 
 
 Number Percent 
Mucosa 2 1.9 
Submucosa 1 0.9 
Muscularis propria 44 41.1 
Cannot be assessed 60 56.1 
Total 107 100.0 
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Table (4): The Lymph node status of the tumor. 
 
 Number Percent 
L.N. not involved and not 
anthracoid 
0 0 
L.N. involved and not 
anthracoid 
1 0.9 
L.N. show anthracosis 24 22.4 
L.N. not present 82 76.6 
Total 107 100.0 
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Table (5): The presence of anthracosis in L.N.s accompanying esophageal resection 
specimens. 
 Number Percent 
No anthracosis 1 4.0 
Anthracosis  24 96.0 
Total  25 100 
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Figure (4): The status of accompanying lymph nodes. 
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Table (6): Concentration of extracted DNA in ng/µ l 
 
 
 N Minimum Maximum Mean Std. 
deviation 
DNA Concentration 
Cases 
35 6.9 521.0 142.9 112.3878 
DNA Concentration 
controls 
11 25.7 180.55 85.85 58.55 
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Table (7): Purity of extracted DNA of cases and controls expressed as absorbance at 
260/ 280 ratio. 
 
A260/A280 Controls Cases 
<1.7 1 4 
1.7- 1.9 5 17 
>1.9 5 14 
Total 11 35 
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Table (8): HPV type 16 results in cases and controls 
 
HPV type 16 Cases Controls 
+ve 3 0 
-ve 32 11 
Total 35 11 
P value 0.0000 
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Table (9): HPV type 18 results in cases and controls 
 
HPV type 18 Cases  Controls  
+ve 21 7 
-ve 14 4 
Total  35 11 
P value 0.23 
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Photo gallery 
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Figure (5): Photograph showing gross appearance of a flat constricting tumor mass 
located at the lower third of the esophagus. 
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Figure (6): A huge fungating tumor mass arising from the middle third of the 
esophagus. 
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Figure (7): An ulcerating malignant ESCC, located at the lower third of the 
esophagus. 
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Figure (8): Photograph showing well formed keratin pearls (arrows) as a feature of 
differentiation in a well differentiated ESCC. ( H& E, 10x objective) 
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Figure (9): Well differentiated ESCC showing preservation of intercellular bridges. 
(H&E 10x objective) 
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Figure 10: Photograph showing poorly differentiated ESCC, note the deeply 
hyperchromatic nuclei. (H&E, 40x objective)  
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Figure (11): Photograph showing high mitotic activity with abnormal mitotic figures 
(arrows) in an ESCC. (H&E, 40 x objectives) 
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Figure (12): Low power view of ESCC, showing invasion by the tumor reaching 
muscularis propria. (H&E 5x objective) 
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Figure (13): High power view of tumor invading and destroying the muscles. ( H&E 
20x objective) 
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Figure (14): Photograph of a lymph node showing tumor secondaries and deposition 
of carbon pigment (anthracosis). (H&E, 40x objective) 
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Figure (15): Photograph of a lymph node showing deposition of carbon pigment 
(anthracosis – arrows) with no tumor secondaries. (H&E, 40x objective) 
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Figure (16):  Gel document of HPV type 16 PCR product (119bp). 
 
Gel document showing DNA 100bp ladder marker in lane one and three product 
bands (119bp- arrow) just above the level of 100bp band of the marker in lanes; 4, 9, 
and 10. The rest of gel wells were loaded by PCR products of apparently negative 
samples. 
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Figure (17): Gel document of HPV type 18 PCR product 112 bp. 
 
Gel document showing labelled lanes. Eight out of eleven wells loaded by amplified 
samples from the study group gave product (112bp) bands at about the level of 100bp 
DNA ladder marker in lanes 4, 5, 7- 12. The rest are negative for HPV18. 
N.B. the lowermost bands in all lanes represent dimerization of primers (non- specific 
annealing).  
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Chapter four
 54
 Discussion 
 
Demographic Features: 
Carcinoma of the esophagus is gaining a lot of interest in Sudan as it is apparently 
increasing in incidence and is showing some interesting demographic features which 
are different from what is reported in other parts of the world. Unfortunately, there is 
no central cancer registry to accurately document the observations made by different 
authors. The fact that the data presented in this study and the recently published data 
are from a single laboratory in Khartoum may not reflect what is happening in the 
country as a whole.  
 The mean age in our study group of ESCC was 54.74 +/- 13 years with two peaks of 
frequency at 28-37years, and 58-69 years respectively.. The age distribution of our 
patients is different from that reported by Boulos in 1977 and Hamo in 1993. who did 
not find a peak for the tumor in young adults. Although the mean age of their patients 
was similar to ours.  
 Kollarova et al 2007 compared results from two international centers from France 
and Czech republic, and found the peak incidence of esophageal  cancer was in the 
50- 70 years age group 3,4. 
The gender distribution of ESCC in this study revealed that 38% of the study group 
were males, 62% were females, with a male to female ratio of 0.6:1. This ratio is in 
contrast to the international 3- 5:1 male to female ratio for esophageal cancer as 
reported in the worldwide cancer registry data4.   A study in Sweden showed a peak 
incidence in male ESCC that occurred in 1985, and then decreased ever since52.  
Malik et al 1976, stated female preponderance (male: female = 0.9: 1) as the only 
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striking feature among esophageal cancer patients in Sudan at that time, in contrast to 
Hamo IM 1993 10 who reported 1.4:1 male to female ratio. The discrepancies in the 
male to female ratio observed by different authors in Sudan may be due to selection of 
cases with regard to their geographic distribution in the country. It is well known that 
esophageal cancer in Kassala area is overwhelmingly a disease of females. Thus any 
study that includes many patients from Kassala will naturally have more females than 
males. This fact in itself is interesting and reasons for preponderance of female cases 
in that area needs to be investigated. Even when we compare the sex ratio of patients 
with esophageal cancer reported by different authors from Sudan we find that the 
marked male preponderance observed in western countries is not a feature of the 
disease in Sudanese patients. Reasons for this are not clear at present.   
Pathological Patterns: 
Tumor Location: 
In the present report there were no data on the site of the tumour in half of the 
cases. Where the site was known about two thirds were in the lower third of the 
esophagus and about one third involved the middle third. According to classical 
textbooks esophageal cancer is most common in the middle of the organ1, 50    . 
Nevertheless, in countries with high incidence of ESCC like Iran, the majority of 
tumors were found to be located in the lower esophagus 54, 56. We stress that more 
prospective, large scale; endoscopically based studies are needed to shed more light 
on the predilection site of esophageal cancer in Sudan.  
Tumor grade: 
The majority of cases were moderately to well differentiated squamous cell 
carcinomas. Adenocarcinoma is rarely encountered.   
Stage of the tumor 
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Attempts at pathological staging via assessing the extent of local infiltration by the 
tumor, were inconclusive in most cases (56.1%) since the diagnosis was based on 
small Endoscopic biopsies which were too small to interpret. Nevertheless, deep 
invasion reaching the muscularis propria and beyond (T2/T3) was the case in 93.6% 
of the cases in which the esophagus was resected. This fact is supported by almost all 
sources in the literature which state the tendency of ESCC to readily invade the 
tissues. 1- 3, 56 
Lymph node status:  
The esophageal resection specimens with accompanying lymph nodes 
comprised only 24% of the cases.   Almost all lymph nodes contained carbon 
pigment. The presence of anthracosis indicates that patients are exposed to inhaled or 
ingested material containing carbon such as soot, burning wood or charcoal, and other 
sources of carbon containing materials. Atmospheric pollution and smoking are also 
known to contribute to anthracosis. No current data have stated such a finding in 
relation to esophageal cancer. 
 
Role of Human Papilloma Virus (HPV) in the etiology of esophageal cancer: 
The association of human papillomavirus (HPV) infections and squamous cell 
cancerous lesions of the esophagus had been suggested since the early 1980s, when 
Syrjanen e59  conducted a histopathological survey on sixty patients with established 
invasive ESCC and noticed the morphological manifestations of HPV in almost 50% 
of cases  . Since that time, accumulating evidence during the past twenty years 
strongly suggests the causal role of HPV in esophageal carcinogenesis.39, 49, 60- 65 
Nevertheless, as yet no firm evidence for the exact role of HPV in esophageal 
carcinogenesis has been provided39, 47, 65-68. Syrjanen 69 reviewed all the studies on 
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HPV and esophageal cancer; and summarized all data with respect to the method 
used, the geographical region, and the type of detected HPV. This meta-analysis 
revealed different rates among different geographical locations and within the same 
regions using different techniques. For example, in South Africa most results were 
within the range of 30- 60 %, ranging from as low as 10% using IHC to as high as 
65% and 67% using histopathological features and PCR respectively. However 
studies from low incidence countries (e.g. USA, Slovenia, Holland, UK, Italy, Japan, 
France, and some regions in China) showed low or no association with the virus47, 70. 
The highest frequencies of HPV infection were seen in the high risk geographical 
locations.6, 39- 42, 44,64,71,72 
In our study, PCR using type specific primers (HPV 16 and 18) was the test 
applied to detect the presence of integrated viral DNA. HPV type 16 was present in 
8.5% (n= 3/35) of the cases and none of the controls, with a statistically significant 
difference (P < 0.001). HPV type 18 was detected in 60% (n= 21/35) of the cases and 
70% (n= 7/11) of the controls, and the difference was statistically insignificant (P > 
0.05). The entire cases positive for HPV type 16 were also positive for HPV type 18. 
The high positive rate of HPV type 18 in the control group is interesting and shows 
that the virus was present in apparently normal esophagus.  Farhadi  62 investigated 
the relationship of HPV and ESCC in Iranian patients compared to esophageal 
specimens from normal subjects as controls. He employed PCR using three types of 
primers; a conserved region and two type specific primers namely, HPV 16 and HPV 
18 and found the following results: Fourteen (36.8%) of the 38 ESCC samples and 
only 5 (13.2%) of the 38 control samples were positive for the HPV L1 gene (P = 
0.02). Five (13.2%) of the ESCC samples but none of the control samples were 
positive for the HPV16 E6/E7 gene (P = 0.05). Three (7.9%) of the ESCC samples 
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and 5 (13.2%) of the control samples were positive for the HPV18 E6/E7 gene (P = 
0.71). Zhong-Ying Shen et al 35, carried out an experiment to verify the role played by 
HPV in carcinogenesis of ESCC; they induced immortalized esophageal epithelial 
cells by E6 and E7 genes of HPV type 18 and followed their biological behavior. 
They concluded that genes E6/E7 of the HPV18 were capable of inducing 
immortalization in fetal esophageal epithelial cells. The immortal phenotype requires 
both activation of telomerase and genetic alterations that alter normal differentiation 
and promote cellular proliferation. 
Zhou et al, 63 investigated the presence of HPV type 16’s DNA in twenty three 
ESCC samples, and adjacent normal mucosa as controls; and found it in 64% of 
ESCC samples and in 34.7% of the adjacent mucosa. 
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Conclusions 
? Esophageal squamous cell cancer occurs in two peaks of age, and shows 
female preponderance in Sudan 
? Anthracosis is a constant interesting feature in accompanying lymph nodes. 
? HPV type 16 is significantly associated with ESCC in our study group. 
? HPV type 18 is highly prevalent in malignant tissues as well as in adjacent, 
apparently normal mucosa; a fact suggestive of its possible role in 
carcinogenesis.   
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Recommendations 
? Proper national cancer registry facility is strongly recommended to throw  
more light on our understanding of esophageal cancer characteristic features in 
Sudan.  
? further large scale studies are recommended to explore the  role of HPV in the 
etiology of ESCC in Sudan. 
?  Clinicians should be encouraged to fill request forms for histopathology 
properly. In particular,  detailed clinical data and location should be clearly 
recorded on endoscopic biopsies.  
? The significance of anthracosis should be thoroughly investigated in future 
studies. 
? Possible other carcinogenic factors for ESCC including environmental and 
social factors need to be investigated. 
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